DeepHealth's AI breast ultrasound software receives FDA clearance, promising improved lesion detection and workflow.
Key Details
- 1DeepHealth Breast Ultrasound AI achieves FDA 510(k) clearance.
- 2The software automates detection, characterization, and reporting of breast lesions.
- 3Validated at over 98% localization accuracy for breast lesions.
- 4Reported 8% increase in sensitivity for breast cancer detection.
- 5Radiologist interpretation time reduced by 37%.
- 6Product to be rolled out across RadNet's imaging centers by year-end.
Why It Matters
This clearance brings a validated AI tool into the clinical workflow, enhancing detection accuracy and efficiency in breast ultrasound exams. Adoption may improve patient outcomes and reduce radiologist workload.
Source
AuntMinnie
Related News
•AuntMinnie
In-House LLM Accurately Flags Critical Pediatric Radiology Findings
A locally deployed LLM system at Stanford Health achieved 99.7% sensitivity for detecting critical results in pediatric radiology reports, supporting workflow automation.
•Radiology Business
New AI Flags Uncertainty in Breast Cancer Imaging Predictions
University of Pittsburgh researchers developed an AI model that quantifies uncertainty in breast cancer diagnostic predictions to enhance trustworthiness.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.